Literature DB >> 17979134

Prognostic significance of the ratio between metastatic and dissected lymph nodes (n ratio) in patients with advanced gastric cancer.

Hiroaki Saito1, Yoji Fukumoto, Tomohiro Osaki, Yoshinori Yamada, Kenji Fukuda, Shigeru Tatebe, Shunichi Tsujitani, Masahide Ikeguchi.   

Abstract

BACKGROUND AND OBJECTIVES: To determine the prognostic significance of the ratio between metastatic and dissected lymph nodes (n ratio) in gastric cancer patients.
METHODS: We retrospectively reviewed 777 advanced gastric cancer patients who had undergone curative gastrectomy at our hospital.
RESULTS: The n ratio was significantly greater in cases with a large tumor, undifferentiated tumor, lymphatic vessel invasion, or blood vessel invasion. Furthermore, the n ratio was significantly correlated with the depth of invasion, level of lymph node metastasis, and number of lymph node metastases. The prognosis for gastric cancer patients correlated well with the n ratio. Multivariate analysis indicated that the n ratio, but not the number of lymph node metastases, was an independent prognostic indicator. Moreover, the n ratio was an independent prognostic factor in N1, N2, and N3 patients defined by the Japanese Classification of Gastric Cancer (JCGC).
CONCLUSIONS: The n ratio is useful for evaluating the status of lymph node metastasis in gastric cancer. Therefore, the addition of the n ratio to the N (nodal) category defined by the JCGC may be a useful strategy in the N-staging classification of gastric cancer.

Entities:  

Mesh:

Year:  2008        PMID: 17979134     DOI: 10.1002/jso.20929

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  24 in total

1.  Superiority of metastatic lymph node ratio to the 7th edition UICC N staging in gastric cancer.

Authors:  Long-Bin Xiao; Jian-Xing Yu; Wen-Hui Wu; Feng-Feng Xu; Shi-Bin Yang
Journal:  World J Gastroenterol       Date:  2011-12-14       Impact factor: 5.742

2.  Prognostic impact of metastatic lymph node ratio in advanced gastric cancer from cardia and fundus.

Authors:  Chang-Ming Huang; Bi-Juan Lin; Hui-Shan Lu; Xiang-Fu Zhang; Ping Li; Jian-Wei Xie
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

3.  Risk stratification for recurrence in patients with esophageal and junctional carcinoma treated with neoadjuvant chemotherapy and surgery.

Authors:  S Dixit; M Tilston; W M Peter
Journal:  Med Oncol       Date:  2009-03-24       Impact factor: 3.064

4.  Short-term outcome of total laparoscopic distal gastrectomy for overweight and obese patients with gastric cancer.

Authors:  Motokazu Sugimoto; Takahiro Kinoshita; Hidehito Shibasaki; Yuichiro Kato; Naoto Gotohda; Shinichiro Takahashi; Masaru Konishi
Journal:  Surg Endosc       Date:  2013-06-21       Impact factor: 4.584

5.  Determining of metastatic lymph node ratio in patients who underwent D2 dissection for gastric cancer.

Authors:  Ahmet Bilici; Mesut Seker; Bala Basak Oven Ustaalioglu; Burcak Yilmaz; Alper Doventas; Taflan Salepci; Mahmut Gumus
Journal:  Med Oncol       Date:  2009-11-03       Impact factor: 3.064

6.  Moving from lymph node metastasis in gastric cancer to biological markers: reply to letter.

Authors:  Naoto Fukuda
Journal:  World J Surg       Date:  2010-05       Impact factor: 3.352

7.  Prognostic significance of the metastatic lymph node ratio in patients with gastric cancer.

Authors:  Sung Ryol Lee; Hyung Ook Kim; Byung Ho Son; Jun Ho Shin; Chang Hak Yoo
Journal:  World J Surg       Date:  2012-05       Impact factor: 3.352

Review 8.  Carcinoma of the gastroesophageal junction in Chinese patients.

Authors:  Qin Huang
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

9.  Prognostic significance of the metastatic lymph node ratio in gastric cancer patients.

Authors:  Naoto Fukuda; Yasuyuki Sugiyama; Akira Midorikawa; Hiroyuki Mushiake
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

10.  New metastatic lymph node ratio system reduces stage migration in patients undergoing D1 lymphadenectomy for gastric adenocarcinoma.

Authors:  Ugwuji N Maduekwe; Gregory Y Lauwers; Carlos Fernandez-Del-Castillo; David L Berger; Charles M Ferguson; David W Rattner; Sam S Yoon
Journal:  Ann Surg Oncol       Date:  2010-01-23       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.